Screener
Castle Biosciences CSTL Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Castle Biosciences’s reported figures.
Based on trailing twelve months.
The source filing: Castle Biosciences’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-031263
FAQ
- What is Castle Biosciences's net margin?
- Castle Biosciences (CSTL) reported net margin of -3.8% in Q1 2026.
- How has Castle Biosciences's net margin changed year-over-year?
- Castle Biosciences's net margin decreased by 158.5% year-over-year, from -1.5% to -3.8%.
- What is the long-term trend for Castle Biosciences's net margin?
- Over 5 years (2020 to 2025), Castle Biosciences's net margin has grown at a -15.6% compound annual growth rate (CAGR), from -16.4% to -7%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Castle Biosciences's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude